ROYALTY PHARMA PLC's ticker is RPRX and the CUSIP is G7709Q104. A total of 331 filers reported holding ROYALTY PHARMA PLC in Q4 2022. The put-call ratio across all filers is 0.58 and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,283,159 | -11.4% | 47,279 | +0.4% | 0.03% | -10.3% |
| Q2 2023 | $1,448,211 | -16.6% | 47,112 | -2.3% | 0.03% | -27.5% |
| Q1 2023 | $1,736,917 | -3.6% | 48,207 | +5.8% | 0.04% | -20.0% |
| Q4 2022 | $1,801,150 | -2.1% | 45,576 | -0.4% | 0.05% | 0.0% |
| Q3 2022 | $1,839,000 | -4.0% | 45,766 | +0.4% | 0.05% | -13.8% |
| Q2 2022 | $1,916,000 | +7.8% | 45,575 | -0.1% | 0.06% | +38.1% |
| Q1 2022 | $1,778,000 | -2.2% | 45,641 | +0.1% | 0.04% | 0.0% |
| Q4 2021 | $1,818,000 | +7.0% | 45,612 | -3.0% | 0.04% | -6.7% |
| Q3 2021 | $1,699,000 | -9.0% | 47,027 | +3.2% | 0.04% | -18.2% |
| Q2 2021 | $1,868,000 | -6.0% | 45,561 | -0.0% | 0.06% | -32.9% |
| Q1 2021 | $1,988,000 | -12.8% | 45,579 | +0.1% | 0.08% | -18.8% |
| Q4 2020 | $2,280,000 | – | 45,550 | – | 0.10% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SIGULER GUFF ADVISERS, LLC | 6,761,970 | $294,957,000 | 88.74% |
| Vantage Consulting Group Inc | 8,705,551 | $379,735,000 | 76.23% |
| Memorial Sloan Kettering Cancer Center | 2,680,644 | $116,930,000 | 72.07% |
| HARVARD MANAGEMENT CO INC | 10,714,284 | $467,357,000 | 26.11% |
| ROBERT WOOD JOHNSON FOUNDATION | 970,151 | $4,231,798,000 | 21.59% |
| Brown University | 381,759 | $16,652,000 | 11.44% |
| Overbrook Management Corp | 771,155 | $33,638,000 | 7.48% |
| SpiderRock Advisors, LLC | 778,800 | $34,236,000 | 4.79% |
| Renaissance Capital LLC | 452,948 | $19,758,000 | 2.93% |
| Lagoda Investment Management, L.P. | 104,835 | $4,573,000 | 2.28% |